Struthers Richard Scott 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Feb 25, 2026
Insider Transaction Report
Form 4
Struthers Richard Scott
DirectorPresident & CEO
Transactions
- Award
Common Stock
[F1]2026-02-23+62,000→ 426,759 total - Award
Stock Option (Right to Buy)
[F2]2026-02-23+228,000→ 228,000 totalExercise: $43.79Exp: 2036-02-23→ Common Stock (228,000 underlying)
Holdings
- 661,205(indirect: By Trust)
Common Stock
- 106,000(indirect: By Trust)
Common Stock
- 110,000(indirect: By Trust)
Common Stock
- 100,000(indirect: By Trust)
Common Stock
- 1,000(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 1, 2027.
- [F2]The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 23, 2026.
Signature
/s/ Tobin Schilke, as attorney-in-fact|2026-02-25